Depotech(depo) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo)

DEPO 7.300

+1.7%

Aug 14 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (850)	10/20/1998 2:02:00 AM
From: Dave K	of 887

rkrw, fair comments. Actually SkyePharma does have sex appeal after a little digging. Nice clients with Watson, SKB, Sepracor etc. Just listed in July and raised $36 mil. so do they have cash. There are still losing money though...think I saw -.81c this year to -.31c projected next. Maybe worth watching ?. I and others will have payed $35 per SKYEY share assuming the contingency payment kicks in at some point. The burn is why this deal could not have waited for FDA word on Cyt and even Phase II results of Morph. Favorable results there would have returned the price to at least $5-$6 IMO. Possible partnerships etc. Is this what they were afraid of ? Geze look at this...what a deal for them / 75c per share for the Depo suckers. b) an additional $0.75 per share, payable if either of the following events occur before March 31, 2000: i) a development agreement is signed with a corporate partner for DepoMorphine, or ii) a development agreement is signed with a corporate partner for a macromolecule using DepoTech's DepoFoam technology Wonder where Chiron fits in all this ? Dave

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next